Papillary serous carcinoma--a less radio-sensitive subtype of endometrial cancer (Q40413116)

20 September 2017

Papillary serous carcinoma--a less radio-sensitive subtype of endometrial cancer (English)

1 reference

20 September 2017

2

Blake Gilks

1 reference

20 September 2017

Joseph D Martin

1

1 reference

PubMed ID

15964062

20 September 2017

Peter Lim

series ordinal

3

1 reference

PubMed ID

15964062

20 September 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

20 September 2017

1 reference

20 September 2017

98

1 reference

20 September 2017

2

1 reference

20 September 2017

299-303

1 reference

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

The radioresponsiveness of human tumours and the initial slope of the cell survival curve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Preoperative radiotherapy and surgery for endometrial carcinoma: prognostic significance of the sterilization of the specimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Uterine papillary serous carcinoma evolves via a p53-driven pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Low-stage clear-cell carcinoma of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Molecular advances in gynecologic oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Inherent radio sensitivity testing of tumor biopsies obtained from patients with carcinoma of the cervix or endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Radiation sensitivity of endometrial carcinoma in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

Differential expression of antiapoptotic genes in human endometrial carcinoma: bcl-XL succeeds bcl-2 function in neoplastic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.009

10.1016/J.YGYNO.2005.04.009

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

15964062